Amplify Weight Loss Drug & Treatment ETF (NY:THNR)
26.54
-0.07
(-0.26%)
Streaming Delayed Price
Updated: 12:27 PM EDT, Aug 12, 2026
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 1,726 |
| Open | 26.50 |
| Bid (Size) | 26.54 (300) |
| Ask (Size) | 26.60 (300) |
| Prev. Close | 26.61 |
| Today's Range | 26.43 - 26.54 |
| 52wk Range | 21.96 - 27.28 |
| Shares Outstanding | 1,300 |
| Dividend Yield | 1.56% |
Top News
More News
3 Ways to Invest in the Growing GLP-1 Weight Loss Market ↗
April 17, 2026
Via MarketBeat
Performance
| YTD |
+4.4%
|
+4.4%
|
| 1 Month |
+3.5%
|
+3.5%
|
| 3 Month |
+6.4%
|
+6.4%
|
| 6 Month |
+1.9%
|
+1.9%
|
| 1 Year |
+20.6%
|
+20.6%
|
More News
Read More
Frequently Asked Questions
Is Amplify Weight Loss Drug & Treatment ETF publicly traded?
Yes, Amplify Weight Loss Drug & Treatment ETF is publicly traded.
What exchange does Amplify Weight Loss Drug & Treatment ETF trade on?
Amplify Weight Loss Drug & Treatment ETF trades on the New York Stock Exchange
What is the ticker symbol for Amplify Weight Loss Drug & Treatment ETF?
The ticker symbol for Amplify Weight Loss Drug & Treatment ETF is THNR on the New York Stock Exchange
What is the current price of Amplify Weight Loss Drug & Treatment ETF?
The current price of Amplify Weight Loss Drug & Treatment ETF is 26.54
When was Amplify Weight Loss Drug & Treatment ETF last traded?
The last trade of Amplify Weight Loss Drug & Treatment ETF was at 08/12/26 12:27 PM ET
What is the market capitalization of Amplify Weight Loss Drug & Treatment ETF?
The market capitalization of Amplify Weight Loss Drug & Treatment ETF is 34.50K
How many shares of Amplify Weight Loss Drug & Treatment ETF are outstanding?
Amplify Weight Loss Drug & Treatment ETF has 35K shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
>